STOCK TITAN

PRIMECAP reports 5.88% Glaukos (NYSE: GKOS) ownership in new 13G filing

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

PRIMECAP Management Company has filed a Schedule 13G reporting beneficial ownership of Glaukos Corporation shares. PRIMECAP reports holding 3,376,928 shares, representing 5.88% of the class as of 12/31/2025. It has sole voting power over 3,374,178 shares and sole dispositive power over 3,376,928 shares.

The firm states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Glaukos. The filing is signed by Deputy Chief Compliance Officer Jorge Antonio Rodriguez on behalf of PRIMECAP Management.

Positive

  • None.

Negative

  • None.

Insights

PRIMECAP reports a 5.88% passive stake in Glaukos.

PRIMECAP Management Company discloses beneficial ownership of 3,376,928 Glaukos shares, equal to 5.88% of the class as of 12/31/2025. It holds sole voting power over 3,374,178 shares and sole dispositive power over the full 3,376,928 shares.

The Schedule 13G certification states the position is held in the ordinary course of business and is not intended to change or influence control of Glaukos. This characterizes PRIMECAP as a passive institutional holder rather than an activist.

The filing indicates a stable, sizeable institutional presence in the shareholder base, but does not describe any transactional changes, timing plans, or control intentions. Future ownership levels will be observable only through subsequent beneficial ownership filings if PRIMECAP’s percentage changes.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



PRIMECAP MANAGEMENT CO/CA/
Signature:Jorge Antonio Rodriguez
Name/Title:Deputy Chief Compliance Officer
Date:02/10/2026

FAQ

How many Glaukos (GKOS) shares does PRIMECAP Management report owning?

PRIMECAP Management reports beneficial ownership of 3,376,928 Glaukos shares. The filing also notes sole voting power over 3,374,178 shares and sole dispositive power over all 3,376,928 shares, reflecting direct control over voting and disposition of this position.

What percentage of Glaukos (GKOS) does PRIMECAP Management own according to the Schedule 13G?

According to the Schedule 13G, PRIMECAP Management owns 5.88% of the outstanding class of Glaukos securities. This percentage is based on beneficial ownership of 3,376,928 shares as of December 31, 2025, crossing the 5% regulatory reporting threshold.

Is PRIMECAP Management’s Glaukos (GKOS) stake reported as passive or for control purposes?

PRIMECAP certifies its Glaukos stake is held in the ordinary course of business and not for changing or influencing control. The filing explicitly states the securities were not acquired and are not held in connection with any control-related transaction, consistent with a passive Schedule 13G filing.

What voting and dispositive powers does PRIMECAP Management have over its Glaukos (GKOS) shares?

PRIMECAP reports sole voting power over 3,374,178 shares and sole dispositive power over 3,376,928 shares. It reports no shared voting or shared dispositive power, indicating exclusive authority over how these shares are voted and whether they are sold or retained.

As of what date is PRIMECAP Management’s Glaukos (GKOS) ownership measured?

PRIMECAP’s ownership figures are measured as of December 31, 2025. The Schedule 13G identifies this as the date of the event requiring the filing, tying the 3,376,928 shares and 5.88% ownership figure to that specific measurement date.
Glaukos Corp

NYSE:GKOS

GKOS Rankings

GKOS Latest News

GKOS Latest SEC Filings

GKOS Stock Data

6.49B
55.54M
3.31%
107.34%
5.9%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
ALISO VIEJO